CoChat

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Gene Therapy

High, Katherine A., Roncarolo, Maria G. · 2019 · New England Journal of Medicine

Abstract

Interview with Dr. Katherine A. High on gene therapy for genetic disease. (15:22)Download Those who have followed the gene-therapy field over the decades may be weary of forward-looking positive statements. However, over the past 3 years, six gene-therapy products have been approved for clinical use. This article describes challenges, risks, and advances in gene-therapy clinical research.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmra1706910

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 73 references

Cited by

See all 568

Metadata

Authors
High, K. A., & Roncarolo, M. G.
Affiliations
Spark Therapeutics (United States) (US)
Venue
New England Journal of Medicine
Published
2019-08
Volume
381
Issue
5
Pages
455-464
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4231146812
Cited by
555
References
73
Citations by year
2026: 76 · 2025: 78 · 2024: 70 · 2023: 63 · 2022: 73 · 2021: 93 · 2020: 88 · 2019: 13
FWCI
8.96
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
gene therapy, genetic disorders, gene therapy products, clinical research challenges
MeSH terms
Dependovirus, Anemia, Sickle Cell, Animals, Genetic Vectors, Humans, Muscular Atrophy, Spinal, Thalassemia, Vision Disorders, Genetic Therapy, Lentivirus, Gene Transfer Techniques, Government Regulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gene Therapy. https://app.cochat.ai/papers/10.1056/nejmra1706910
The paper
High, K. A., & Roncarolo, M. G. (2019). Gene Therapy. New England Journal of Medicine. https://doi.org/10.1056/nejmra1706910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.